Renaissance International IPO ETF (IPOS)
| Assets | $4.39M |
| Expense Ratio | 0.60% |
| PE Ratio | 19.28 |
| Shares Out | 350,001 |
| Dividend (ttm) | $0.11 |
| Dividend Yield | 0.91% |
| Ex-Dividend Date | Dec 13, 2024 |
| Payout Ratio | 17.71% |
| 1-Year Return | -10.84% |
| Volume | 1,976 |
| Open | 12.42 |
| Previous Close | 12.38 |
| Day's Range | 12.35 - 12.42 |
| 52-Week Low | 12.00 |
| 52-Week High | 14.84 |
| Beta | 0.73 |
| Holdings | 40 |
| Inception Date | Oct 6, 2014 |
About IPOS
Fund Home PageThe Renaissance International IPO ETF (IPOS) is an exchange-traded fund that is based on the Renaissance International IPO index. The fund tracks a cap-weighted index of recent IPOs listed internationally. The fund adds an IPO within three years of its initial listing. IPOS was launched on Oct 6, 2014 and is issued by Renaissance.
Top 10 Holdings
64.21% of assets| Name | Symbol | Weight |
|---|---|---|
| Galderma Group AG | GALD | 8.53% |
| PT Amman Mineral Internasional Tbk | AMMN | 8.25% |
| J&T Global Express Limited | 1519 | 7.33% |
| Dr. Ing. h.c. F. Porsche AG | P911 | 7.32% |
| PT Barito Renewables Energy Tbk | BREN | 7.08% |
| SenseTime | 20.HK | 6.47% |
| PT GoTo Gojek Tokopedia Tbk | GOTO | 5.42% |
| CVC Capital Partners | CVC.AS | 5.07% |
| Definity Financial Corporation | DFY | 4.43% |
| Socionext Inc. | 6526 | 4.33% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 13, 2024 | $0.007 | n/a |
| Sep 13, 2024 | $0.018 | Sep 20, 2024 |
| Jun 14, 2024 | $0.088 | Jun 21, 2024 |
| Sep 15, 2023 | $0.029 | Sep 22, 2023 |
| Jun 16, 2023 | $0.017 | Jun 23, 2023 |
| Dec 18, 2020 | $0.069 | Dec 28, 2020 |
News
Even A Depressed IPO Market Can Produce (AI) Stars
IPO activity in 2023 remained subdued compared to pre-pandemic years despite expectations of a surge. IPO experts are now predicting a resurgence in new stock offerings for 2024, but projections keep ...
U.S. IPO Weekly Recap: 2024 IPO Market Starts Off With $2B Additions To The Pipeline
While the calendar was quiet this past week, six IPOs joined the pipeline, two of which we estimate could raise $1 billion or more. Three biotechs filed to raise $100 million.
US IPO Weekly Recap: IPO Pipeline Adds Another Sizable Name Amid More Small Listings
One small IPO priced this week, along with one SPAC that began trading. Three IPOs and four SPACs joined the pipeline. Offshore transport services provider Hornbeck Offshore Services filed to raise $1...
U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO
Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late. As of 11/2/2023, the Renaissance IPO Index was up 23.5% year-to-date, while the S&P 500 was...
Arm deal is expected to lift tech IPOs, but not all future debuts will have the same draw
The strong debut of Arm Holdings Plc. is expected to reignite the long-dormant IPO market for tech companies, but not all the current deals in the pipeline will have the same draw for investors.
U.S. IPO Weekly Recap: August Wraps Up With 1 Nano-Cap
There was just one pricing this past week, which was excluded from our IPO stats, while holdover biotech Adlai Nortye did not get done. Filing activity reached a six-month high in August, and six issu...
U.S. IPO Weekly Recap: Atmus Launches $275 Million IPO And Restaurant Chain CAVA Joins The Pipeline
Two small deals priced this past week, neither of which were eligible for inclusion in our IPO stats, while one issuer delayed to the week ahead. The week's news was driven by Cummins spin-off Atmus F...
U.S. IPO Weekly Recap: Pipeline News Disrupts An Otherwise Silent Week For The IPO Market
No IPOs began trading or submitted initial filings this past week, as the sole scheduled deal, Strong Global Entertainment, was delayed to the week ahead. Vietnamese EV maker, VinFast, announced plans...
Searching For Momentum In The IPO Drought
Poor market conditions effectively shut down the U.S. IPO (initial public offering) market in 2022. We analyzed previous IPO droughts (2003 and 2008) to assess when the market may rebound.
U.S. IPO Weekly Recap: No IPOs, But Pipeline Gets A $350 Million Pick Up From Cummins Spin-Off Atmus
The IPO market was quieter than expected this past week. Both deals on the calendar delayed, and there was no wave of post-Presidents' Day launches. With no large post-Presidents' Day launches this pa...
U.S. IPO Weekly Recap: 3 Micro-Cap IPOs Come To Market During The February Lull
The Arena Group, a media holding company operating Sports Illustrated, TheStreet, and other brands, raised $30 million at a $172 million market cap. Nine SPACs went public this past week.
The IPO Boom Isn't Just About The Equity Market
A healthy IPO market has provided a timely windfall for many non-investment grade issuers looking to deleverage after a challenging 2020.
Many 2021 IPOs fall flat on first trading day. Unpacking the performance
Renaissance Capital Chairman, principal and co-founder Kathleen Smith breaks down why some of this year's initial public offerings haven't performed as well as expected. With CNBC's Bob Pisani.
Is The SPAC Party Over?
The SPAC market has somewhat reset from the initial euphoria. SPACs will continue to provide a useful and efficient avenue to take private companies public.
US IPO Weekly Recap: The IPO Market Cools Off In A 2 IPO Week
Just two IPOs priced this past week, raising $222 million as the US IPO market continued to cool down. The IPO pipeline remained active, with 13 IPOs and 14 SPACs submitting initial filings this week.
U.S. IPO Week Ahead: Biotechs Break The Post-Election Ice In A 2 IPO Week
Oncology biotech IN8bio plans to raise $75 million at a $325 million market cap. Clinical-stage biotech Inhibikase Therapeutics plans to raise $15 million at a $142 million market cap.
Ant Group IPO: These ETFs could be first to have access, analyst says
Todd Rosenbluth, senior director of ETF and mutual fund research at CFRA Research, flags the ETFs to watch in relation to the Ant Group IPO, which could be the largest debut in history.
How to use ETFs to play Ant Group's historic Shanghai-Hong Kong dual listing, possibly one of the biggest IPOs ever
ETF analysts share some ways U.S. investors can get in on Alipay parent Ant Group's upcoming dual listing in Shanghai and Hong Kong.
How to play Ant Group's dual listing, possibly one of the biggest IPOs ever
Todd Rosenbluth, senior director of ETF and mutual fund research at CFRA Research, and Chris Hempstead, director of institutional business development at New York Life's IndexIQ, share some ways to tr...
